BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 113040
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.113040
Table 2 Pathology and age group of the study participants, n (%)
Characteristics
65-69 years
70-74 years
75-79 years
80-84 years
85-89 years
χ2 (df)
P value
Preoperative3.17 (4)0.558
    No31 (41.9)23 (31.1)13 (17.6)5 (6.8)2 (2.7)
    Yes13 (54.2)5 (20.8)3 (12.5)1 (4.2)2 (8.3)
Treatment type4.79 (8)0.756
    Neoadjuvant7 (43.8)7 (43.8)2 (12.5)0 (0)0 (0)
    Palliative surgery1 (33.3)1 (33.3)1 (33.3)0 (0)0 (0)
    Surgery36 (45.6)20 (25.3)13 (16.5)6 (7.6)4 (5.1)
Operation type9.43 (4)0.046
    Laparoscopy26 (44.1)21 (35.6)10 (16.9)1 (1.7)1 (1.7)
    Open surgery18 (46.2)7 (17.9)6 (15.4)5 (12.8)3 (7.7)
PT stage10.61 (12)0.544
    T11 (50.0)0 (0)1 (50.0)0 (0)0 (0)
    T210 (50.0)7 (35.0)1 (5.0)1 (5.0)1 (5.0)
    T317 (34.0)16 (32.0)4 (8.0)3 (6.0)3 (6.0)
    T416 (61.5)5 (19.2)1 (3.8)0 (0)0 (0)
PN stage16.83 (8)0.027
    N020 (44.4)7 (15.6)13 (28.9)2 (4.4)3 (6.7)
    N111 (42.3)11 (42.3)1 (3.8)3 (11.5)0 (0)
    N213 (48.1)10 (37.0)2 (7.4)1 (3.7)1 (3.7)
M stage4.48 (4)0.357
    M011 (37.9)8 (27.6)5 (17.2)2 (6.9)3 (10.3)
    M133 (47.8)20 (29.0)11 (15.9)4 (5.8)1 (1.4)
Stage11.99 (12)0.431
    Stage 13 (42.9)0 (0)2 (28.6)1 (14.3)1 (14.3)
    Stage 25 (35.7)5 (35.7)3 (21.4)0 (0)1 (7.1)
    Stage 33 (37.5)3 (37.5)0 (0)1 (12.5)1 (12.5)
    Stage 433 (47.8)20 (29.0)11 (15.9)4 (5.8)1 (1.4)
Tumour size (mm)27.70 ± 25.1117.80 ± 18.5224.36 ± 21.2221.98 ± 12.4512.81 ± 4.82-0.341


Write to the Help Desk